News Releases

An MGH-led research team has identified an immune cell protein that is critical to setting off the body's initial response against viral infection. The report describes finding that a protein called GEF-H1 is essential to the ability of macrophages – major contributors to the innate immune system – to respond to viral infections like influenza.

Study identifies protein essential for innate immune recognition, response to viral infection

Mice lacking GEF-H1 protein expression unable to mount immune defense against influenza

24/Nov/2013

A Massachusetts General Hospital (MGH)-led research team has identified an immune cell protein that is critical to setting off the body's initial response against viral infection.  The report that will be published in an upcoming issue of Nature Immunology and is receiving early online release describes finding that a protein called GEF-H1 is essential to the ability of macrophages – major contributors to the innate immune system – to respond to viral infections like influenza.

"The detection of viral genetic material inside an infected cell is critical to initiating the responses that signal the immune system to fight an infection and prevent its spread throughout the body," says Hans-Christian Reinecker, MD, of the Center for the Study of Inflammatory Bowel Disease in the MGH Gastrointestinal Unit, senior author of the report.  "Our findings indicate that GEF-H1 may control immune responses against a wide variety of RNA and DNA viruses that pose a threat to human health."

The body's first line of defense against infection, the innate immune system rapidly responds to invading pathogens by mobilizing white blood cells, chemical factors called cytokines and antimicrobial peptides.  When viruses invade cells, they often move towards the nucleus in order to replicate and sometimes to integrate their own genetic material into that of the host cell, traveling along structures called microtubules that cells use for internal protein transport.  But how microtubule-based movement of viral components contributes to induction of the immune response has been unknown.

Confocal microscopic image showing red-tagged GEF-H1 protein – which appears to be essential to the immune response against viral infection – within a cell's microtubule network. (Hans-Christian Reinecker, MD, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital)


GEF-H1 is known to bind to microtubules, and previous research indicated that it has a role in immune recognition of bacteria.  A series of experiments by Reinecker's team found that GEF-H1 is expressed in macrophages – key components of the innate immune system – and activated in response to viral RNA and that it controls the expression of beta interferon and other cytokines.  Mice in which expression of GEF-H1 was knocked out were unable to mount an effective immune response to influenza A and to encephalomyocarditis, a virus that causes several types of infection in animals.

"The sensing of intracellular viral nucleic acids for induction of interferons is so important that many viruses, including influenza A, have evolved specific strategies to interfere with activation of the interferon defense system," says Reinecker, an associate professor of Medicine at Harvard Medical School.  "We are hopeful that this discovery will allow the development of new strategies to curtail viral mechanisms that impede the immune responses to infections that are often associated with high mortality rates."

The co-lead authors of the Nature Immunology report are Hao-Sen Chiang, PhD, and Yun Zhao, MD, PhD, MGH Gastrointestinal Unit.  Additional co-authors are Joo-Hye Song, PhD, Song Liu, MD, Megha Basavappa and Kate Jeffrey, PhD, MGH Gastrointestinal Unit; Ninghai Wang, MD, PhD, and  Cox Terhorst, Beth Israel Deaconess Medical Center; and Arlene Sharpe, MD, PhD, Harvard Medical School.  The study was supported by National Institutes of Health grants AI093588, DK-068181, DK-033506, 630 DK-043351 and DK-52510.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $775 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.

 

Media Contacts: Sue McGreevey, smcgreevey@partners.org, 617-724-2764

patient

U.S. News and World Report Best Hospitals 2014-2015

U.S. News & World Report ranks Mass General #1 in New England and #2 in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.

Search the Mass General news archive

Search the archive for previously published news articles, press releases and publications.

View all departments

Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.